34 | AntigensIBA
03/2024
-
01/2007 |
20 | Chimeric Antigen ReceptorsIBA
12/2023
-
01/2010 |
19 | Proteins (Proteins, Gene)FDA Link
03/2024
-
09/2004 |
9 | CytokinesIBA
02/2024
-
01/2010 |
9 | Peptides (Polypeptides)IBA
09/2023
-
01/2007 |
7 | AntibodiesIBA
01/2023
-
08/2006 |
5 | EpitopesIBA
01/2023
-
01/2007 |
5 | Bispecific AntibodiesIBA
09/2014
-
06/2011 |
5 | AutoantibodiesIBA
01/2010
-
03/2005 |
4 | Neoplasm Antigens (Tumor Antigens)IBA
03/2021
-
05/2006 |
4 | AutoantigensIBA
11/2012
-
08/2006 |
3 | T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2021
-
01/2011 |
2 | bispidineIBA
03/2024
-
11/2022 |
2 | Lysine (L-Lysine)FDA Link
03/2024
-
11/2017 |
2 | Biomarkers (Surrogate Marker)IBA
02/2024
-
08/2017 |
2 | Capsules (Microcapsules)IBA
01/2024
-
06/2023 |
2 | Chelating AgentsIBA
12/2023
-
07/2017 |
2 | Surface Antigens (Surface Antigen)IBA
09/2023
-
01/2010 |
2 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2022
-
01/2016 |
2 | MicroRNAs (MicroRNA)IBA
11/2022
-
09/2020 |
2 | Immune Checkpoint InhibitorsIBA
01/2020
-
03/2018 |
2 | Programmed Cell Death 1 ReceptorIBA
01/2020
-
03/2018 |
2 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
10/2018
-
07/2017 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
10/2018
-
01/2016 |
2 | LuciferasesIBA
10/2018
-
11/2017 |
2 | CatecholaminesIBA
10/2018
-
01/2016 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
07/2017
-
01/2016 |
2 | DNA (Deoxyribonucleic Acid)IBA
07/2015
-
08/2006 |
2 | Toll-Like Receptors (Toll-Like Receptor)IBA
07/2013
-
03/2011 |
2 | AndrogensIBA
06/2011
-
09/2005 |
2 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2006
-
09/2004 |
1 | Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
04/2024 |
1 | Interleukin-2 (IL2)IBA
04/2024 |
1 | Fibronectins (Fibronectin)IBA
03/2024 |
1 | picolinic acid (chromium picolinate)IBA
03/2024 |
1 | LigandsIBA
03/2024 |
1 | ThioureaIBA
03/2024 |
1 | Immunoconjugates (Immunoconjugate)IBA
03/2024 |
1 | Fc Receptors (Fc Receptor)IBA
02/2024 |
1 | Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2024 |
1 | Trastuzumab (Herceptin)FDA Link
02/2024 |
1 | Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
02/2024 |
1 | BilirubinIBA
02/2024 |
1 | Lipase (Acid Lipase)FDA Link
02/2024 |
1 | Lactic Acid (Lactate)FDA LinkGeneric
02/2024 |
1 | Actins (F Actin)IBA
01/2024 |
1 | Radioisotopes (Radionuclides)IBA
12/2023 |
1 | AlginatesIBA
06/2023 |
1 | ChitosanIBA
06/2023 |
1 | Transforming Growth Factor beta (TGF-beta)IBA
01/2023 |
1 | Carcinoembryonic AntigenIBA
01/2023 |
1 | Epithelial Cell Adhesion MoleculeIBA
01/2023 |
1 | GoldIBA
01/2023 |
1 | HLA-G Antigens (HLA G)IBA
11/2022 |
1 | Messenger RNA (mRNA)IBA
03/2022 |
1 | Heavy Chain Fusion Regulatory Protein 1IBA
03/2022 |
1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2022 |
1 | AlbuminsIBA
01/2022 |
1 | RadiopharmaceuticalsIBA
01/2022 |
1 | Ghrelin ReceptorsIBA
03/2021 |
1 | GhrelinIBA
03/2021 |
1 | endothelial PAS domain-containing protein 1IBA
01/2021 |